Aerovate Therapeutics, Inc. (JBIO) Bozor qiymatining balans qiymatiga nisbati
Aerovate Therapeutics Inc (JBIO) kasalliklarga maqsadli ta'sir ko'rsatuvchi innovatsion kukunsimon imatinibni ishlab chiqish orqali o'pka patologiyalarini davolashga ixtisoslashgan. Immun agentlarining ishlab chiqarish sikllari qat'iy tozalik nazoratiga ega bo'lgan shartnomaviy ishlab chiqarish maydonlariga tayanadi, u yerda samaradorlik ko'rsatkichi 2.04 hisoblanadi. GURU.Markets platformasidagi qimmatqog'ozlarning ushbu narx harakati gipertoniya uchun inhalatsiya terapiyasining ishlab chiqilishini aks ettiradi, uning klinik muvaffaqiyati va foydalanish qulayligi ulkan bozorga kirish imkonini beradi.
Aerovate Therapeutics Inc (JBIO) - koʻrsatkichlar kesimi va moliyaviy hisobotlar
- bozor qiymati va tahlilchilarning maqsadli prognozi:
- bozor kapitallashuvi tafsilotlari:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz majburiyatlari va likvidlik statistikasi:
Qarzning xususiy kapitalga nisbati Aerovate Therapeutics Inc|JBIO - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati aerovatetx.com|JBIO - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Aerovate|JBIO - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli majburiyatlari Aerovate Therapeutics Inc|Tezkor likvidlik koeffitsiyenti aerovatetx.com
- foyda va baholash multiplikatorlari ko'rsatkichlari:
Kompaniyaning asosiy tahlili:Aerovate Therapeutics, Inc. - JBIO
Inhalyatsiya qilinadigan sunitinib orqali o'pka arterial gipertenziyasi uchun tengsiz parvarish standartini joriy etish bilan Aerovate Therapeutics Inc (JBIO) sezilarli nomoddiy biznes qiymatini yaratmoqda. Joriy bozor qiymatining buxgalteriya qiymatiga nisbati tendentsiyasini tahlil qilish orqali investor aksiyalarning bozor narxi va sof aktivlar o'rtasidagi farqni baholaydi, bu esa kotirovkalarga kiritilgan kelajakdagi ortiqcha foyda kutsimalarining darajasini aniqlash imkonini beradi va kapitalning haddan tashqari qimmat yoki arzon baholanganini o'z vaqtida aniqlashga xizmat qiladi.
Raqobatchilar tahlili
argenx SE (ARGX) - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti biontech.de (BNTX)|Bozor qiymatining balans qiymatiga nisbati abivax.com|ADMA Biologics Inc - Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati PTGX|IMVT (Immunovant Therapeutics) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati KNSA (Kiniksa Pharmaceuticals)|Bozor kapitallashuvining balans qiymatiga nisbati grifols.com GRFS|ADPT - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati CLDX (Celldex Therapeutics Inc)|Aurinia Pharma (AUPH) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati BioCryst Corp|VERA (Vera Therapeutics, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati dianthustx.com|Kapitallashuvning sof aktivlarga nisbati PHVS (Pharvaris)|ABCL (AbCellera Biologics) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati TRML (Tourmaline Corp)|Balans qiymatiga nisbatan bozor kapitallashuvi Precigen Corp (PGEN)|PHAR - Bozor qiymatining balans qiymatiga nisbati|nektar.com (NKTR) - Kapitallashuvning sof aktivlarga nisbati|Upstream Bio (UPB) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Zenas Bio|Kapitallashuvning sof aktivlarga nisbati IMNM|Bozor kapitallashuvining balans qiymatiga nisbati Gossamer Bio Corp.|Bozor qiymatining balans qiymatiga nisbati KalVista Pharmaceuticals (KALV)|septerna.com - Kapitallashuvning balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati PVLA (Pieris Pharmaceuticals, Inc.)|Savara Inc (SVRA) - Bozor qiymatining balans qiymatiga koeffitsiyenti|Rigel Pharmaceuticals Inc - Bozor kapitallashuvining balans qiymatiga nisbati|ANAB - Bozor kapitallashuvining balans qiymatiga nisbati|ATXS: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti engene.com (ENGN)|Bozor qiymatining balans qiymatiga nisbati RAPT Therapeutics|ACRS: Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati Kyverna (KYTX)|TLSA - Bozor qiymatining balans qiymatiga koeffitsiyenti|Cabaletta Bio, Inc. - Kapitallashuvning sof aktivlarga nisbati|ventyxbio.com - Bozor qiymatining balans qiymatiga nisbati|Theratechnologies - Bozor kapitallashuvining balans qiymatiga nisbati|AVTX - Bozor kapitallashuvining balans qiymatiga nisbati|ELDN (Eledon) - Kapitallashuvning sof aktivlarga nisbati|AGEN: Bozor kapitallashuvining balans qiymatiga multiplikatori|CLYM (Climb Bio Inc) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti zurabio.com ZURA|Kapitallashuvning sof aktivlarga nisbati ATYR (aTyr Pharma)|ADAG (adagene.com) - Balans qiymatiga nisbatan bozor qiymati|Ikena Oncology - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga multiplikatori STTK (Shattuck Labs Inc)|Equillium Bio - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati CNTB (Connect Biopharma)|IMUX: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Atara Bio (ATRA)|Bozor qiymatining balans qiymatiga nisbati InflaRx NV|XFOR: Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati ACET|Bozor kapitallashuvining balans qiymatiga nisbati celularity.com (CELU)|Bozor qiymatining balans qiymatiga nisbati INmune Bio INMB|BRNS (Barinthus Biotherapeutics PLC) - Sof aktivlarga nisbatan bozor kapitallashuvi|Kezar Life Sciences, Inc - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti SAB Biotherapeutics Inc|AKTX (Akari Therapeutics) - Kapitallashuvning sof aktivlarga nisbati|Enlivex Therapeutics Ltd. (ENLV) - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati QTTB|GOVX (GeoVax Labs) - Bozor kapitallashuvining balans qiymatiga multiplikatori|Bozor kapitallashuvining balans qiymatiga nisbati EDSA|Balans qiymatiga nisbatan bozor kapitallashuvi iBio Corporation|Bozor kapitallashuvining balans qiymatiga nisbati CARM (Carisma Therapeutics Inc.)|XTLB - Kapitallashuvning sof aktivlarga nisbati|BOLT - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi HCW Biologics Inc. HCWB|APVO (aptevotherapeutics.com) - Kapitallashuvning sof aktivlarga nisbati|aimimmuno.com - Balans qiymatiga nisbatan bozor qiymati|ADTX (Aditxt Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|gribio.com (GRI) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati XORTX Therapeutics (XRTX)|Vyome Holdings Inc. - Kapitallashuvning balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati REVB (Revelation Bio)|INDP - Kapitallashuvning sof aktivlarga nisbati|SCNI - Bozor qiymatining balans qiymatiga nisbati|CalciMedica, Inc. - Bozor kapitallashuvining balans qiymatiga multiplikatori|AFMD: Bozor kapitallashuvining balans qiymatiga nisbati|ALLK (Allakos) - Bozor qiymatining balans qiymatiga nisbati|HOOK (HOOKIPA Pharma, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|IGM Bio (IGMS) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati iTeos Therapeutics (ITOS)|OCEA - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati TC BioPharm TCBP|THRD (Third Harmonic Bio Inc.) - Sof aktivlarga nisbatan bozor kapitallashuvi